Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,410 | 1,449 | 1,448 | 1,463 | 1,446 |
| Income taxes - deferred | -57 | 228 | -261 | 120 | 233 |
| Accounts receivable | 10,741 | -1,890 | 484 | 3,198 | -3,469 |
| Other Working Capital | 2,384 | -1,646 | 3,499 | 2,777 | -2,289 |
| Other Operating Activity | -6,285 | 3,466 | 371 | -207 | 8,294 |
| Operating Cash Flow | $8,193 | $1,607 | $5,541 | $7,351 | $4,215 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -2 | -4 | -16 | -28 |
| Net Acquisitions | -445 | -320 | -1,747 | -576 | -569 |
| Purchase Sale Intangibles | N/A | -216 | 0 | 0 | N/A |
| Investing Cash Flow | $-477 | $-538 | $-1,751 | $-592 | $-597 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -37,572 | -1,428 | N/A |
| Debt Issued | N/A | 0 | 17,584 | 0 | 0 |
| Debt Repayment | -3,359 | -2,695 | -1,806 | -454 | -33 |
| Common Stock Issued | N/A | 0 | 7,606 | N/A | N/A |
| Other Financing Activity | -1,136 | -1,265 | -970 | -1,080 | -935 |
| Financing Cash Flow | $-4,495 | $-3,960 | $-15,158 | $-2,962 | $-968 |
| Exchange Rate Effect | -22 | -67 | 80 | -78 | 63 |
| Beginning Cash Position | 5,255 | 8,213 | 19,501 | 15,782 | 13,069 |
| End Cash Position | 8,454 | 5,255 | 8,213 | 19,501 | 15,782 |
| Net Cash Flow | $3,221 | $-2,891 | $-11,368 | $3,797 | $2,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,193 | 1,607 | 5,541 | 7,351 | 4,215 |
| Capital Expenditure | -32 | -218 | -4 | -16 | -28 |
| Free Cash Flow | 8,161 | 1,389 | 5,537 | 7,335 | 4,187 |